Fair Value Calculator Fair Value Calculator
EN DE

SUCHITRA (SUCHITRA) Fair Value & Analysis

IN · Market cap ₹587M

S SUCHITRA SUCHITRA · BSE
Price₹40.03
Fair Value₹83.54
Upside+108.7%
Quality58/100
Watch SUCHITRA for free — get notified when fair value or trend changes. Watch for free
Evidence: Medium Range ₹65.28 – ₹109.78

Fair value as of: Jul 6, 2026

From 23 valuation models · updated yesterday

Share price +0.1% over the past month.

Price vs Fair Value (12 months)

₹44.40 ₹26.88 Fair Value ₹83.54 Jun 2025 Jul 2026

12‑month range ₹26.88 – ₹44.40 · fair‑value band ₹65.28 – ₹109.78 · the ₹40.03 price screens below the ₹83.54 fair value. As of Jul 6, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

SUCHITRA (SUCHITRA) currently trades at ₹40.03, while our model-based Fair Value estimate is ₹83.54 — implying the stock looks roughly 108.7% undervalued today. We read business quality at 58/100 (solid quality). Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

Net debt stands at ₹329M. The stock trades on a trailing P/E of 5.9. Fundamentals as of Jul 6, 2026

Our scenario range runs from ₹65.28 (bear case) to ₹109.78 (bull case); at ₹40.03, the current price sits below that range. The share trades about 20% below its 52-week high and 57% above its 52-week low, currently above its 200-day average.

Key figures & financial health

Return on equity 646%
Free cash flow ₹204M FY2022
P/E ratio 5.9
Dividend yield 1.9%
Net debt ₹329M FY2022

Figures from reported company fundamentals (EODHD) · as of Jul 6, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2018 – FY2022 · reported fiscal years

SUCHITRA reported revenue of ₹125M in FY2022 versus ₹331M in FY2018, a compound −21.6%/yr. Reported net income was ₹64.4M in FY2022, compounding −8.9%/yr from FY2018.

Revenue −21.6%/yr
FY18 ₹331M
FY19 ₹216M
FY20 ₹219M
FY21 ₹153M
FY22 ₹125M
Net income −8.9%/yr
FY18 ₹93.3M
FY19 ₹90.6M
FY20 ₹59.3M
FY21 ₹75.5M
FY22 ₹64.4M

Is SUCHITRA fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "SUCHITRA Fair Value". https://www.fairvalue-calculator.com/stock/SUCHITRA

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is SUCHITRA (SUCHITRA) undervalued?
As of Jul 6, 2026, our model estimates a fair value of ₹83.54 versus a price of ₹40.03 — about +109% (undervalued). Model-based estimate, not financial advice.
What is the fair value of SUCHITRA?
Our model-based fair value for SUCHITRA is ₹83.54 (as of Jul 6, 2026), built from audited fundamentals. The current price is ₹40.03.
What is the quality score of SUCHITRA?
SUCHITRA has a Quality Score of 58/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the net profit margin of SUCHITRA?
The net profit margin of SUCHITRA is about 0.0%, meaning it keeps roughly 0.0% of revenue as net income. Based on the latest reported figures.
Does SUCHITRA pay a dividend?
SUCHITRA currently shows a dividend yield of about 1.92% relative to its recent price (as of Jul 6, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.